文献速递脑血管病外科神经重症

使用 Barrow 破裂动脉瘤试验(BRAT)队列对蛛网膜下腔出血国际试验者(SAHIT)预测模型进行外部验证

External Validation of the Subarachnoid Hemorrhage International Trialists (SAHIT) Predictive Model Using the Barrow Ruptured Aneurysm Trial (BRAT) Cohort.
PubMed 文献 · Neurosurgery · 2020-01-01

该研究是对前瞻性随机对照试验 BRAT 的事后分析,共纳入 338 例动脉瘤性蛛网膜下腔出血患者,用于外部验证 SAHIT 预测模型。研究构建了核心模型、神经影像模型和完整模型,三个模型对不良结局和死亡的判别能力(AUC)均处于中等水平,且校准良好,校准指标落在 SAHIT 研究产生的 95% CI 内。作者认为该模型可用于向患者及家属交代动脉瘤性 SAH 后的预后。

要点

  • 在 BRAT 队列中外部验证 SAHIT 模型,共纳入 338 例动脉瘤性 SAH 患者。
  • 不良结局的三个模型 AUC 分别为 0.728、0.732、0.734,死亡的 AUC 分别为 0.721、0.739、0.744。
  • 所有模型校准良好,校准指标落在 SAHIT 研究产生的 95% CI 内。

核心结论

  • 使用 BRAT 数据外部验证了 SAHIT 模型对 SAH 后不良结局和死亡的预测能力。
  • 该模型可用于向患者及家属交代动脉瘤性 SAH 后的预后。

研究设计与样本

  • 本研究为对前瞻性随机对照试验 BRAT 的事后分析。
  • 共纳入 338 例患者(平均年龄 54 岁;67.7% 为良好临床分级;平均动脉瘤大小 6.7 mm;84.1% 为前循环)。
  • 构建了三个模型:核心模型(年龄、高血压、世界神经外科医师联盟分级)、神经影像模型(动脉瘤大小/位置、Fisher 评分)和完整模型(模型 1 和 2 加治疗类型)。
  • 通过判别能力(曲线下面积 [AUC])和校准(拟合优度检验、整体校准、校准斜率)评价模型性能。

主要发现

  • 由于大量交叉,接受夹闭的动脉瘤多于栓塞(67.5% vs 32.5%)。
  • 10.1% 的患者死亡,29.6% 出现不良结局。
  • 对于不良结局,三个模型的 AUC 分别为 0.728、0.732 和 0.734。
  • 对于死亡,三个模型的 AUC 分别为 0.721、0.739 和 0.744。
  • 总体上所有模型均显示良好校准,校准指标落在 SAHIT 研究产生的 95% CI 内。

临床怎么用

  • 作者认为该模型可用于向患者及家属交代动脉瘤性 SAH 后的预后。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: The Subarachnoid Hemorrhage International Trialists (SAHIT) repository is a collection of randomized clinical trials, prospective observational studies, and hospital registries that was used to create a predictive model of unfavorable outcome/mortality following aneurysmal SAH. OBJECTIVE: To externally validate the SAHIT model using Barrow Ruptured Aneurysm Trial (BRAT) data, which was not included in the SAHIT repository. METHODS: This is a post hoc analysis of the prospective, randomized BRAT. Three models were created: (1) Core (age, hypertension, World Federation of Neurosurgical Societies grade), (2) neuroimaging (aneurysm size/location, Fisher score), and (3) full model (model 1 and 2 plus treatment type). The performance of the models was evaluated by measures of model discrimination (area under the curve [AUC]) and model calibration (goodness of fit test, calibration in-the-large, calibration slope). RESULTS: A total of 338 patients (average age 54 years; 67.7% good clinical grade; average aneurysm size 6.7 mm; 84.1% anterior circulation) were included. Due to a large number of crossovers, more aneurysms were clipped than coiled (67.5% vs 32.5%, respectively). A total of 10.1% of the patients died and 29.6% experienced an unfavorable outcome. For unfavorable outcome, the AUCs for the three models were: 0.728, 0.732, and 0.734, respectively. For mortality, the AUCs for the three models were: 0.721, 0.739, and 0.744, respectively. Overall, all models showed good calibration, and the measures of calibration fell within 95% CI of those produced in the SAHIT study. CONCLUSION: Using the BRAT data, we have externally validated the SAHIT model for predicting unfavorable outcome and mortality after SAH. The model may be used to counsel patients and families on prognosis following aneurysmal SAH.

来源:Neurosurgery,查看原文。版权归原作者所有。

引用

  1. Mascitelli JR, Cole T, Yoon S, et al. External Validation of the Subarachnoid Hemorrhage International Trialists (SAHIT) Predictive Model Using the Barrow Ruptured Aneurysm Trial (BRAT) Cohort. Neurosurgery. 2020. PMID: 30566611. doi:10.1093/neuros/nyy600

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。